These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. How to investigate and treat: headache and hyperprolactinemia. Bussone G; Usai S; Moschiano F Curr Pain Headache Rep; 2012 Aug; 16(4):365-70. PubMed ID: 22639180 [TBL] [Abstract][Full Text] [Related]
23. [Current diagnosis and treatment of hyperprolactinemia]. Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213 [TBL] [Abstract][Full Text] [Related]
24. [Pituitary tumor syndrome and hyperprolactinemia in peripheral hypothyroidism]. Abram M; Brue T; Morange I; Girard N; Guibout M; Jaquet P Ann Endocrinol (Paris); 1992; 53(5-6):215-23. PubMed ID: 1340688 [TBL] [Abstract][Full Text] [Related]
25. Hyperprolactinemia in cases of infertility and amenorrhea. Furuhjelm M; Rydner T; Carlström K Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290 [TBL] [Abstract][Full Text] [Related]
26. [Hyperprolactinemia in the postmenopause: versions and contraversions]. Leshchenko OY Ter Arkh; 2021 Oct; 93(10):1234-1239. PubMed ID: 36286827 [TBL] [Abstract][Full Text] [Related]
27. Cabergoline in the long-term therapy of hyperprolactinemic disorders. Ferrari C; Paracchi A; Mattei AM; de Vincentiis S; D'Alberton A; Crosignani P Acta Endocrinol (Copenh); 1992 Jun; 126(6):489-94. PubMed ID: 1642081 [TBL] [Abstract][Full Text] [Related]
28. Hyperprolactinemia/Prolactinomas in the Postmenopausal Period: Challenges in Diagnosis and Management. Pekić S; Medic Stojanoska M; Popovic V Neuroendocrinology; 2019; 109(1):28-33. PubMed ID: 30347396 [TBL] [Abstract][Full Text] [Related]
29. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients. Lu CC; Hsieh CJ Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536 [TBL] [Abstract][Full Text] [Related]
30. The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia. Corenblum B; Donovan L Fertil Steril; 1993 Mar; 59(3):671-3. PubMed ID: 8458475 [TBL] [Abstract][Full Text] [Related]
31. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up. Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418 [TBL] [Abstract][Full Text] [Related]
32. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. Colao A; Vitale G; Cappabianca P; Briganti F; Ciccarelli A; De Rosa M; Zarrilli S; Lombardi G J Clin Endocrinol Metab; 2004 Apr; 89(4):1704-11. PubMed ID: 15070934 [TBL] [Abstract][Full Text] [Related]
33. Pituitary prolactin-secreting tumor formation: recent developments. Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432 [TBL] [Abstract][Full Text] [Related]
34. [Hyperprolactinemia: unusual association between peripheral hypothyroidism and microprolactinoma]. Chafik A; El Mghari G; El Ansari N Pan Afr Med J; 2016; 24():41. PubMed ID: 27642382 [TBL] [Abstract][Full Text] [Related]
35. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea. Davajan V; Kletzky O; March CM; Roy S; Mishell DR Am J Obstet Gynecol; 1978 Apr; 130(8):894-904. PubMed ID: 565142 [TBL] [Abstract][Full Text] [Related]
36. Falsely low serum prolactin in two cases of invasive macroprolactinoma. Schöfl C; Schöfl-Siegert B; Karstens JH; Bremer M; Lenarz T; Cuarezma JS; Samii M; von zur Mühlen A; Brabant G Pituitary; 2002; 5(4):261-5. PubMed ID: 14558675 [TBL] [Abstract][Full Text] [Related]